Retrospective analysis to identify prognostic parameters for response to immune checkpoint blockade in non small cell lung cancer patients
Recruiting
- Conditions
- C34Malignant neoplasm of bronchus and lung
- Registration Number
- DRKS00012643
- Lead Sponsor
- niversitätsklinikum TübingenMedizinische Klinik II
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Non small cell lung cancer patients treated with immune checkpoint blockade
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Restrospective correlation of clinical, laboratory, radiomorphological and histological paramaters before start of therapy with response in first restaging
- Secondary Outcome Measures
Name Time Method Analysis of parameters stated above regarding progression free survival and overall survival